Imago BioSciences
0 followers
‌
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Org chart
Hugh Y. Rienhoff, Jr.
Collapse
Michael Arenberg
Chief Operating & Business Officer
Wan-Jen Hong
Chief Medical Officer
Amy E. Tapper
SVP, Non-Clinical & CMC
Allison Anderson, MAS
Head of People & Talent
Amy Tapper
Chief Technology Officer
Cassandra Celatka
Exec. Director, Drug Discovery and Development
Enoch Kariuki
Board Director, Audit Chair
Joshua Giguere
Director, Drug Substance CMC
Maria Kleppe
Senior Director, Scientific Discovery
Nivedita Namdev
Senior Director, Medicinal Chemistry
Randy Corley
Director, Clinical Quality Compliance
Sahar Wazen
Senior Quality Management System (QMS) Manager
Sangati Gandhi
Director Program Management
Stephanie Roland
Vice President Regulatory Affairs
Xi Chen
Director, Analytical Chemistry
Philippa Quy
Clinical Trial Manager
